home / stock / kymr / kymr short
Short Information | Kymera Therapeutics Inc. (NASDAQ:KYMR)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,632,955 |
Total Actual Volume | 12,200,912 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 81,648 |
Average Short Percentage | 15.18% |
Is there a KYMR Short Squeeze or Breakout about to happen?
See the KYMR Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $30.95 | $30.22 | $31.24 | $29.52 | 363,160 | 62,532 | 17.22% |
07-01-2024 | $29.87 | $30.95 | $31.48 | $29.33 | 566,962 | 77,173 | 13.61% |
06-28-2024 | $30.21 | $29.85 | $30.42 | $29.24 | 1,548,900 | 108,857 | 7.03% |
06-27-2024 | $30.08 | $30.22 | $30.85 | $29.59 | 572,968 | 96,138 | 16.78% |
06-26-2024 | $31.01 | $29.89 | $31.01 | $29.73 | 551,342 | 61,837 | 11.22% |
06-25-2024 | $31.39 | $31.15 | $31.975 | $31 | 735,274 | 87,300 | 11.87% |
06-24-2024 | $32.31 | $31.45 | $32.8 | $31.41 | 416,084 | 79,737 | 19.16% |
06-21-2024 | $31.51 | $31.99 | $32.26 | $31.25 | 1,690,217 | 94,241 | 5.58% |
06-20-2024 | $30.95 | $31.27 | $32.08 | $30.2 | 506,197 | 114,084 | 22.54% |
06-18-2024 | $31.7 | $31.2 | $31.89 | $30.77 | 495,994 | 88,891 | 17.92% |
06-17-2024 | $33 | $31.82 | $33.21 | $31.2 | 677,812 | 186,604 | 27.53% |
06-14-2024 | $34.46 | $33.29 | $34.87 | $33.19 | 408,448 | 60,556 | 14.83% |
06-13-2024 | $34.51 | $34.87 | $34.985 | $34.07 | 347,960 | 63,287 | 18.19% |
06-12-2024 | $35.93 | $34.6 | $36.62 | $33.9 | 446,355 | 101,299 | 22.69% |
06-11-2024 | $33.94 | $34.57 | $35 | $33.58 | 413,397 | 79,611 | 19.26% |
06-10-2024 | $32.38 | $34.26 | $34.37 | $32.01 | 806,608 | 64,085 | 7.94% |
06-07-2024 | $32.44 | $32.96 | $33.46 | $32.265 | 310,106 | 46,768 | 15.08% |
06-06-2024 | $33.69 | $32.87 | $33.69 | $32.25 | 343,323 | 34,996 | 10.19% |
06-05-2024 | $32.24 | $33.87 | $34 | $31.76 | 465,233 | 58,978 | 12.68% |
06-04-2024 | $31.46 | $31.94 | $32.59 | $31.15 | 534,572 | 65,981 | 12.34% |
News, Short Squeeze, Breakout and More Instantly...
Kymera Therapeutics Inc. Company Name:
KYMR Stock Symbol:
NASDAQ Market:
Kymera Therapeutics Inc. Website:
PALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western world. The prevalence rate of panc...
KT-333 demonstrated initial clinical proof of concept across multiple hematological malignancies, including complete responses in two patients with Hodgkin’s lymphoma Robust STAT3 knockdown and positive immunomodulatory effect achieved in blood and tumor KT-333 was well-t...
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement and potent upregulation of p53 pathway biomarkers even at the lowest dose levels in solid tumo...